Evidence for a synergistic effect of the HIV-1 envelope protein gp120 and brain-derived neurotrophic factor (BDNF) leading to enhanced expression of somatostatin neurons in aggregate cultures derived from the human fetal cortex

Brain Research

Volumn 815, Issue 2, 1999, Pages 349-357

  Barnea, Ayalla ^a   Roberts, Jodie ^a   Ho, Raymond H ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

BDNF; Brain; gp120; Neuropeptide Y; Neurotrophin; Peptidergic neuron; SRIF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; LACTATE DEHYDROGENASE; NEUROPEPTIDE Y; SOMATOSTATIN;

ARTICLE; BRAIN; CELL AGGREGATION; CELL CULTURE; COGNITIVE DEFECT; ENCEPHALITIS; ENZYME ACTIVITY; FETUS; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; DRUG SYNERGISM; FETUS; GESTATIONAL AGE; HIV ENVELOPE PROTEIN GP120; HUMANS; NEURONS; NEUROPEPTIDE Y; SOMATOSTATIN;

EID: 0033537332     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01098-1     Document Type: Article

References (51)

1. Aguila-Mansilla N., Barnea A. Human fetal brain cells in aggregate culture: a model system to study regulatory processes of the developing human neuropeptide Y (NPY) producing neuron. Int. J. Dev. Neurosci. 14:1996;531-539.
2. Aguila-Mansilla N., Little B.B., Ho R.H., Barnea A. Differential potencies of cocaine and its metabolites, cocaethylene and benzoylecgonine, in suppressing the functional expression of somatostatin and neuropeptide Y producing neurons in cultures of fetal cortical cells. Biochem. Pharmacol. 54:1997;491-500.
3. Barnea A., Aguila-Mansilla N., Chute H.T., Welcher A.A. Comparison of neurotrophin regulation of human and rat neuropeptide Y (NPY) neurons: induction of NPY production in aggregate cultures derived from rat but not from human fetal brains. Brain Res. 732:1996;52-60.
4. Barnea A., Aguila-Mansilla N., Lu G., Ho R.H. Opposite effects of astrocyte-derived soluble factor(s) on the functional expression of fetal peptidergic neurons in aggregate cultures: enhancement of neuropeptide Y and suppression of somatostatin. J. Neurosci. Res. 50:1997;605-617.
5. Barnea A., Anthony E., Lu G., Cho G. Morphological differentiation of neuropeptide Y neurons in aggregate cultures of dissociated fetal cortical cells: a model system for glia-neuron paracrine interactions. Brain Res. 625:1993;313-322.
6. Barnea A., Cho G., Hajibeigi A., Aguila M.C., Magni P. Dexamethasone induced accumulation of neuropeptide Y by aggregating fetal brain cells in culture: a process dependent on the developmental-age of the aggregates. Endocrinology. 129:1991;931-938.
7. Barnea A., Cho G., Lu G. Role for glial cells in regulating the functional expression of neuropeptide Y (NPY) neurons in aggregate cultures derived from fetal brain cells. J. Neurosci. Res. 38:1994;459-467.
8. Barnea A., Cho G., Lu G., Mathis M. Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide Y producing neurons. J. Neurosci. Res. 42:1995;638-647.
9. Barnea A., Cramer O., Cho G. Truncated insulin-like growth factor-I: A potent inducer of neuropeptide Y production by aggregate cultures of fetal brain cells. Endocrine J. 1:1993;11-17.
10. Barnea A., Hajibeigi A., Cho G., Magni P. Regulated production and secretion of immunoreactive neuropeptide Y by aggregating fetal brain cells in culture. Neuroendocrinology. 54:1991;7-13.
11. Bouras C., Magistretti P.J., Morrison J.H., Constantinidis J. An immunohistochemical study of pro-somatostatin-derived peptides in the human brain. Neuroscience. 22:1987;781-800.
12. Chan Palay V. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia. J. Comp. Neurol. 260:1987;201-223.
13. Civitello L.A. Neurologic complications of HIV infection in children. Pediatr. Neurosurg. 17:1991;104-112.
14. Da Cunha A., Mintz M., Eiden L.E., Sharer L.R. A neuronal and neuroanatomical correlate of HIV-1 encephalopathy relative to HIV-1 encephalitis in HIV-1-infected children. J. Neuropathol. Exp. Neurol. 56:1997;974-987.
15. Da Cunha A., Rausch D.M., Eiden L.E. An early increase in somatostatin mRNA expression in the frontal cortex of rhesus monkeys infected with simian immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 92:1995;1371-1375.
16. Dawson V.L., Dawson T.M., Uhl G.R., Snyder S.H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 90:1993;3256-3259.
17. Elkabes S., DiCicco-Bloom E.M., Black I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16:1996;2508-2521.
18. Everall I.P., Luthert P.J., Lantos P.L. Neuronal loss in the frontal cortex in HIV infection[see comments]. Lancet. 337:1991;1119-1121.
19. Fox L., Alford M., Achim C., Mallory M., Masliah E. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56:1997;360-368.
20. Gelbard H.A., James H.J., Sharer L.R., Perry S.W., Saito Y., Kazee A.M., Blumberg B.M., Epstein L.G. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathology and Applied Neurobiology. 21:1995;208-217.
21. Grant I., Atkinson J.H. The evolution of neurobehavioral complications of HIV infection. Psychol. Med. 20:1990;747-754.
22. Heese K., Hock C., Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70:1998;699-707.
23. Ho R.H., DePalatis L.R. Substance P immunoreactivity in the median eminence of the North American opossum and domestic fowl. Brain Res. 189:1980;565-569.
24. Hornung J.P., de Tribolet N., Tork I. Morphology and distribution of neuropeptide-containing neurons in human cerebral cortex. Neuroscience. 51:1992;363-375.
25. Kaiser P.K., Offermann J.T., Lipton S.A. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology. 40:1990;1757-1761.
26. Klein R., Nanduri V., Jing S.A., Lamballe F., Tapley P., Bryant S., Cordon-Cardo C., Jones K.R., Reichardt L.F., Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 66:1991;395-403.
27. Kowall N.W., Ferrante R.J., Beal M.F., Richardson E.P., Sofroniew M.V., Cuello A.C., Martin J.B. Neuropeptide Y, somatostatin, and reduced nicotinamide XX XX adenine dinucleotide phosphate diaphorase in the human XX XX striatum: a combined immunocytochemical and enzyme histochemical XX XX study. Neuroscience. 20:1987;817-828.
28. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Ann. Biochem. 102:1980;344-352.
29. Lannuzel A., Barnier J.V., Hery C., Tan H.V., Guilbert B., Gray F., Vincent J.D., Tardieu M. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated proteins kinases in human neurons. Ann. Neurol. 42:1997;847-856.
30. Levy J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:1993;183-289.
31. Lipton S.A., Sucher N.J., Kaiser P.K., Dreyer E.B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 7:1991;111-118.
32. Mathern G.W., Babb T.L., Pretorius J.K., Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J. Neurosci. 15:1995;3990-4004.
33. Merril J.E., Chen I.Y. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5:1991;2391-2397.
34. Meucci O., Miller R.J. gp120-Induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-β1. J. Neurosci. 16:1996;4080-4088.
35. Miwa T., Furukawa S., Nakajima K., Furukawa Y., Kohsaka S. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 50:1997;1023-1029.
36. Mizuno K., Carnahan J., Nawa H. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev. Biol. 165:1994;243-256.
37. Muller W.E., Schroder H.C., Ushijima H., Dapper J., Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur. J. Pharmacol. 226:1992;209-214.
38. Mulroney S.E., McDonnel K.J., Pert C.B., Ruff M.R., Resch Z., Samson W.K., Lumpkin M.D. HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanisms for the pathogenesis of AIDS wasting. Proc. Natl. Acad. Sci. USA. 95:1998;1927-1932.
39. Nawa H., Bessho Y., Carnahan J., Nakanishi S., Mizuno K. Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J. Neurochem. 60:1993;772-775.
40. Nawa H., Pelleymounter M.A., Carnahan J. Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 14:1994;3751-3765.
41. Ong W.Y., Garey L.J. Distribution of GABA and neuropeptides in the human cerebral cortex. A light and electron microscopic study. Anat. Embryol. 183:1991;397-413.
42. Pulliam L., Herndier B.G., Tang N.M., McGrath M.S. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87:1991;503-512.
43. Pulliam L., West D., Haigwood N., Swanson R.A. HIV-1 envelope gp120 alters astrocytes in human brain cultures. Aids Res. Human Retrovir. 9:1993;439-444.
44. Schindler M., Humphrey P.P., Emson P.C. Somatostatin receptors in the central nervous system. Prog. Neurobiol. 50:1996;9-47. [Review] [255 refs].
45. B. Shi, U.D. Girolami, J. He, S. Wang, A. Lorenzo, J. Busciglio, D. Gabuzda, Apoptosis induced by HIV-1 infection of the central nervous system, J. Clin. Invest., Vol. 98, 1996, pp. 1979-1980.
46. Sindou P., Couratier P., Esclaire F., Yardin C., Bousseau A., Hugon J. Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzole. J. Neurol. Sci. 126:1994;133-137.
47. V. Soontornniyomkij, G. Wang, C.A. Pittman, C.A. Wiley, C.L. Achim, Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis, Neuropathol. Appl. Neurobiol., In Press (1998).
48. Squinto S.P., Stitt T.N., Aldrich T.H., Davis S., Bianco S.M., Radziejewski C., Glass D.J., Masiakowski P., Furth M.E., Valenzuela D.M.et al. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell. 65:1991;885-893.
49. Vecsei L., Widerlov E. Brain and CSF somatostatin concentrations in patients with psychiatric or neurological illness. An overview. Acta Psychiatr. Scand. 78:1988;657-667. [Review].
50. Wu P., Price P., Du B., Hatch W.C., Terwilliger E.F. Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. Neuroreport. 7:1996;1045-1049.
51. Yeung M.C., Pulliam L., Lau A.S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through induction of interleukin-6 and tumor necrosis factor-alpha. AIDS. 9:1995;137-143.